Insulin sensitive human adipocytes for in vitro studies

[1]  L. Aronne,et al.  Tirzepatide Once Weekly for the Treatment of Obesity. , 2022, The New England journal of medicine.

[2]  R. Jaenisch,et al.  Development of a physiological insulin resistance model in human stem cell–derived adipocytes , 2022, bioRxiv.

[3]  M. Tschöp,et al.  Anti-obesity drug discovery: advances and challenges , 2021, Nature reviews. Drug discovery.

[4]  Karl Z Nadolsky,et al.  Once-Weekly Semaglutide in Adults with Overweight or Obesity. , 2021, The New England journal of medicine.

[5]  J. Elmquist,et al.  Leptin: Less Is More , 2020, Diabetes.

[6]  Luca Truscello,et al.  Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity , 2019, Diabetologia.

[7]  Norma E. Conner,et al.  Advances and Challenges , 2016, The American journal of hospice & palliative care.

[8]  Rahul C. Deo,et al.  Programming human pluripotent stem cells into white and brown adipocytes , 2012, Nature Cell Biology.

[9]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[10]  P. Iyengar,et al.  The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.

[11]  Simon Regard,et al.  ["Less is more"]. , 2013, Revue medicale suisse.

[12]  Tran Van Nhieu G.  Pathogenic paradox? , 1999, Trends in microbiology.